DETROIT - Researchers have discovered a link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in some people. Most people encounter cytomegalovirus (CMV) during childhood, and after the initial infection the virus remains in the body for life, usually dormant. By the age of 80, 9 out of 10 people will have CMV's telltale antibodies in their
ANN ARBOR–After a successful pilot program, BioVigil announced it will launch full production of its hand wash system, AccuWash, which observes and records a health provider’s handwashing compliance. AccuWash uses thermal energy and a set of sophisticated sensors inside a sink beacon. When the beacon senses a user’s hands under the faucet, it starts a
SAN FRANCISCO - UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition. Pancreatic cancer is less common than these other cancers, but the lack of treatment options makes it more deadly, and it claims more than 50,000 lives
ANN ARBOR - As 2023 ends, MichBio reflects on the impact its team made on Michigan’s life sciences industry. While there were certainly challenges along the way, MichBio said it is proud of the work its done and hope you’ve noticed its efforts to convene, connect, inform, and advocate for the statewide life sciences cluster.
DAVIS, Ca. - Scientists have just discovered a way to kill off cancerous cells, a new process that could improve cancer treatment. A research team from the University of California, Davis (UCD) Comprehensive Cancer Center has found a method to detonate the mechanism that leads to the heart of cancerous tumors. The result, which was
DETROIT–Generative artificial intelligence is everywhere, including now the pharmaceutical clinical trial industry. TrialAssure, a company advancing trial results disclosure and data sharing in the pharmaceutical industry, has created and published clinical trial results in plain language summary format, posting directly to TrialResults.com. The documents were created using clinical data provided by the clinical trial sponsors
NEW YORK - The successful transfer of a gene that produces HMW-HA paves the way for improving the health and lifespan of humans, too. In a groundbreaking endeavor, scientists at the University of Rochester have successfully transferred a longevity gene from naked mole rats to mice, leading to enhanced health and a longer lifespan for the mice.
NEW YORK - Absence of Chinmo in imaginal cells suppresses wing growth (left) compared to control wing precursor tissue (middle), while overexpression of the Chinmo gene induces tissue overgrowth, as occurs in processes tumors (right). Credit: IBE Researchers discover Chimno, the gene responsible for the juvenile stage in insects. This gene is present in mammals
JERUSALEM, Israel - An experimental treatment developed at Israel's Hadassah-University Medical Center has a 90% success rate at bringing patients with multiple myeloma into remission. Hadassah-University Medical Center in Jerusalem’s Ein Kerem has announced an “unprecedented achievement” in the treatment of multiple myeloma cancer – the second-most common hematological disease. It accounts for one-tenth of all
NEW YORK - In a significant groundbreaking medical development, researchers have created a tiny device, smaller than a grain of rice, to deliver drugs directly to the pancreatic tumor. In the near future, this implantable nanofluidic device could be a game changer in treating pancreatic cancer. Nanomedicine experts at Houston Methodist Academic Institute developed the
